Glioblastoma multiforme (GBM) is an aggressive brain tumor with high mortality rates. Due to
its invasiveness, heterogeneity, and incomplete resection, the treatment is very challenging …

Liposomal formulations entrapping a vast number of molecules have improved cancer
therapies overcoming certain pharmacokinetic (PK) and pharmacodynamic limitations, many …

Renal cell carcinoma (RCC) is a common urinary tract tumor that arises from the highly
heterogeneous epithelium of the renal tubules. The incidence of kidney cancer is second …

The field of theranostics has been rapidly growing in recent years and nanotechnology has
played a major role in this growth. Nanomaterials can be constructed to respond to a variety …

The conventional medications are still facing a huge challenge for the treatment of
rheumatoid arthritis (RA). Thus, looking for an effective therapy of RA has became an urgent …

Renal cell carcinoma (RCC) is a common urological malignancy and represents a leading
threat to healthcare. Recent years have seen a series of progresses in the early diagnosis …

The kidney is a vital organ responsible for maintaining homeostasis in the human body.
However, renal cell carcinoma (RCC) is a common malignancy of the urinary system and …

Ultrasound with low frequency (20–100 kHz) assisted drug delivery has been widely
investigated as a non-invasive method to enhance the permeability and retention effect of …

Recent progress in nanomedicine and targeted therapy brings new breeze into the field of
therapeutic applications of tyrosine kinase inhibitors (TKIs). These drugs are known for many …

According to the WHO, cancer caused almost 10 million deaths worldwide in 2020, ie,
almost one in six deaths. Among the most common are breast, lung, colon and rectal and …